Spontaneous regression of essential thrombocythemia with MPL mutation on menopause.

Abstract excerpt

Essential thrombocythemia (ET) is a subtype of myeloproliferative neoplasms. Approximately half of the patients with ET harbor a gain-of-function mutation in the JAK2 gene (JAK2-V617F), a small percentage have mutations in codon 515 of MPL (thrombopoietin receptor) gene, and the rest have neither mutation. Pregnancy is a rare complication of ET, and it has been reported that the number of blood platelets falls...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to JAK2 gene
• Share to MPL gene
• Share to Menopause